Literature DB >> 28774866

Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification.

Hong Kuan Kok1, Hamed Asadi, Mark Sheehan, Frank P McGrath, Mark F Given, Michael J Lee.   

Abstract

PURPOSE: We aimed to evaluate limb salvage, defined as freedom from major amputation, and to identify predictors of major amputation in patients with infrapopliteal peripheral arterial disease (PAD) based on the updated 2015 TASC II anatomic classification treated by percutaneous transluminal angioplasty (PTA).
METHODS: This was a retrospective study of infrapopliteal PTA procedures performed for PAD over a 4-year period. Patient demographics, medical comorbidities, risk factors, angiographic imaging, technical details, and clinical follow-up were analyzed to determine limb salvage rates, technical success, and all-cause mortality. Predictors of major amputation following PTA were identified.
RESULTS: A total of 112 patients were treated by infrapopliteal PTA. Most lesions consisted of TASC C (44%) and D (34%) categories, were over 10 cm in length, and were occlusive and heavily calcified (89%). Overall technical success was 75%, with limb salvage rates of 77% at 1 year and 65% at 3 years following PTA. Smoking, previous stroke or cardiovascular events, and anticoagulation use were associated with an increased risk of major amputation following PTA.
CONCLUSION: PTA of complex infrapopliteal PAD is associated with good intermediate term limb salvage rates.

Entities:  

Mesh:

Year:  2017        PMID: 28774866      PMCID: PMC5602360          DOI: 10.5152/dir.2017.17040

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  25 in total

1.  One-Year Outcomes Following Directional Atherectomy of Infrapopliteal Artery Lesions: Subgroup Results of the Prospective, Multicenter DEFINITIVE LE Trial.

Authors:  Aljoscha Rastan; James F McKinsey; Lawrence A Garcia; Krishna J Rocha-Singh; Michael R Jaff; Elias Noory; Thomas Zeller
Journal:  J Endovasc Ther       Date:  2015-10-07       Impact factor: 3.487

2.  Amputation-Free Survival after Crural Percutaneous Transluminal Angioplasty for Critical Limb Ischemia.

Authors:  M Strøm; L Konge; L Lönn; T V Schroeder; P Rørdam
Journal:  Scand J Surg       Date:  2015-02-06       Impact factor: 2.360

3.  Long-term outcomes following 282 consecutive cases of infrapopliteal PTA and association of risk factors with primary patency and limb salvage.

Authors:  Fragiska Sigala; Elissaios Kontis; Wolfang Hepp; Konstantinos Filis; John Melissas; Petros Mirilas
Journal:  Vasc Endovascular Surg       Date:  2012-02-16       Impact factor: 1.089

4.  Long-Term Clinical Outcomes of Infrapopliteal Drug-Eluting Stent Placement for Critical Limb Ischemia in Diabetic Patients.

Authors:  Stavros Spiliopoulos; Vasiliki Theodosiadou; Konstantinos Katsanos; Panagiotis Kitrou; George C Kagadis; Dimitris Siablis; Dimitris Karnabatidis
Journal:  J Vasc Interv Radiol       Date:  2015-08-04       Impact factor: 3.464

5.  Below knee angioplasty in elderly patients: predictors of major adverse clinical outcomes.

Authors:  Aoife N Keeling; Karim Khalidi; Sum Leong; Tim T Wang; Alaa S Ayyoub; Frank P McGrath; Thanos Athanasiou; Michael J Lee
Journal:  Eur J Radiol       Date:  2009-09-17       Impact factor: 3.528

6.  Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.

Authors:  Fabrizio Fanelli; Alessandro Cannavale; Emanuele Boatta; Mario Corona; Pierleone Lucatelli; Andrea Wlderk; Carlo Cirelli; Filippo Maria Salvatori
Journal:  J Endovasc Ther       Date:  2012-10       Impact factor: 3.487

7.  Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs.

Authors:  Kristina A Giles; Frank B Pomposelli; T L Spence; Allen D Hamdan; Seth B Blattman; Haig Panossian; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2008-05-23       Impact factor: 4.268

8.  Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia.

Authors:  Syed N Haider; Eamon G Kavanagh; Martin Forlee; Mary P Colgan; Prakash Madhavan; Dermot J Moore; Gregor D Shanik
Journal:  J Vasc Surg       Date:  2006-03       Impact factor: 4.268

9.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini; David B Snead; K Craig Kent; Krishna J Rocha-Singh
Journal:  J Am Coll Cardiol       Date:  2014-10-14       Impact factor: 24.094

10.  Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).

Authors:  Thomas Zeller; Ulrich Beschorner; Ernst Pilger; Marc Bosiers; Koen Deloose; Patrick Peeters; Dierk Scheinert; Karl-Ludwig Schulte; Aljoscha Rastan; Marianne Brodmann
Journal:  JACC Cardiovasc Interv       Date:  2015-10       Impact factor: 11.195

View more
  1 in total

1.  Mortality and chronic obstructive pulmonary disease in patients treated with endovascular revascularization of the infra-inguinal lower limb arteries from retrograde access.

Authors:  Zoltan Ruzsa; Rafał Januszek; Viktor Óriás; Michał Chyrchel; Joanna Wojtasik-Bakalarz; Jerzy Bartuś; Saleh Arif; Paweł Kleczyński; Tomasz Tokarek; Andras Nyerges; Agata Stanek; Dariusz Dudek; Stanisław Bartuś
Journal:  Ann Transl Med       Date:  2020-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.